Bronstein, Gewirtz & Grossman, LLC Is Investigating Corcept Therapeutics Incorporated (CORT) And Encourages Stockholders to Connect
NEW YORK CITY, NY / ACCESS Newswire / February 25, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential ...
PharmiWeb11h
Formycon receives regulatory approval in the UK for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand name AHZANTIVE®
Regulatory ApprovalFormycon receives regulatory approval in the UK for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand name AHZANTIVE® 25.02.2025 / 06:30 CET/CESTThe issuer is solely ...
PharmiWeb2h
Radiation-Induced Myelosuppression Treatment Market to Reach USD 3.5 Billion by 2028 with a 3.1% of CAGR
Radiation-Induced Myelosuppression Treatment MarketThe global Radiation-Induced Myelosuppression Treatment Market is ...
SMTC DEADLINE NOTICE: BFA Law Alerts Semtech Corp. Investors that Lost Money to Contact the Firm by the April 22 Class Action Deadline
New York, New York-- (Newsfile Corp. - February 25, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Semtech Corp. (NASDAQ: SMTC) and ...
Gastric Cancer Global Market Report 2025: Impressive Global Market Trends And Leading Industry Players In Oncology
The Business Research Company Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
JD Supra22h
FDA Accepts U.S. Biologics License Application for AVT06, Alvotech and Teva’s Proposed Aflibercept Biosimilar
Alvotech and Teva Pharmaceuticals (“Teva”) announced that the U.S. Food and Drug Administration (FDA) has accepted for review ...
Taiwan News18h
Penicillin Drug Market to Reach $12.08 Billion by 2032, Growing at 3.7% CAGR
The global penicillin drug market size was valued at US$ 8.71 billion in 2023 and is projected to reach US$ 12.08 billion by 2032, registering a CAGR of 3.7% during the forecast period from 2024 to ...
TALTZ’S Rapid Market Ascent Reflects Its Unparalleled Ability To Transform The Treatment Landscape For Autoimmune Diseases | Delveinsight
TALTZ (ixekizumab), an IL-17A inhibitor by Eli Lilly, has shown strong market growth driven by increasing adoption in psoriasis, psoriatic arthritis, ...
CovNews19h
Takeda in Stanton Springs unveils Biomedical Waste Processing Facility
Takeda, a global biopharmaceutical company with a manufacturing site in Stanton Springs, unveiled its new Biomedical Waste ...
Future Market Insights23h
Anemia Treatment Market Set to Reach USD 23,903.5 Million by 2035 at a 6.9% of CAGR
Anemia Treatment Market. The global anemia treatment market is projected to grow from USD 12,287.3 million in 2025 to USD ...
Future Market Insights23h
Benign Prostatic Hyperplasia (BPH) Prostate Treatment Market Set to Reach USD 47,045.80 Million by 2034 at a 3.6% of CAGR
The global benign prostatic hyperplasia (BPH) prostate treatment market is projected to grow from USD 33.03 billion in 2024 ...